User profiles for Deepika Dhawan
 | Dr. Deepika DhawanAssistant Professor Verified email at ggn.amity.edu Cited by 165 |
Abdominal obesity, adipokines and non-communicable diseases
Abdominal obesity may be defined as excess deposits of fat in the abdominal region. It is a
common health condition seen in South Asians and is positively related to non-…
common health condition seen in South Asians and is positively related to non-…
[HTML][HTML] Comparative gene expression analyses identify luminal and basal subtypes of canine invasive urothelial carcinoma that mimic patterns in human invasive …
D Dhawan, M Paoloni, S Shukradas, DR Choudhury… - PloS one, 2015 - journals.plos.org
More than 160,000 people are expected to die from invasive urothelial carcinoma (iUC) this
year worldwide. Research in relevant animal models is essential to improving iUC …
year worldwide. Research in relevant animal models is essential to improving iUC …
[HTML][HTML] Naturally-occurring invasive urothelial carcinoma in dogs, a unique model to drive advances in managing muscle invasive bladder cancer in humans
DW Knapp, D Dhawan, JA Ramos-Vara… - Frontiers in …, 2020 - frontiersin.org
There is a great need to improve the outlook for people facing urinary bladder cancer, especially
for patients with invasive urothelial carcinoma (InvUC) which is lethal in 50% of cases. …
for patients with invasive urothelial carcinoma (InvUC) which is lethal in 50% of cases. …
Pentamidine is an inhibitor of PRL phosphatases with anticancer activity
MK Pathak, D Dhawan, DJ Lindner, EC Borden… - Molecular cancer …, 2002 - AACR
The PRL family oncogenic phosphatases are attractive targets for developing inhibitors as
anticancer therapeutics given their potentially pathogenic role in human malignancies. Herein …
anticancer therapeutics given their potentially pathogenic role in human malignancies. Herein …
Homologous mutation to human BRAF V600E is common in naturally occurring canine bladder cancer—Evidence for a relevant model system and urine-based …
B Decker, HG Parker, D Dhawan, EM Kwon… - Molecular Cancer …, 2015 - AACR
Targeted cancer therapies offer great clinical promise, but treatment resistance is common,
and basic research aimed at overcoming this challenge is limited by reduced genomic and …
and basic research aimed at overcoming this challenge is limited by reduced genomic and …
Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development
…, JA Ramos-Vara, GE Moore, D Dhawan… - ILAR …, 2014 - academic.oup.com
Each year more than 65,000 people are diagnosed with urinary bladder cancer, and more
than 14,000 people die from the disease in the United States. Studies in relevant animal …
than 14,000 people die from the disease in the United States. Studies in relevant animal …
Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer
D Dhawan, JA Ramos-Vara, JC Stewart… - … Oncology: Seminars and …, 2009 - Elsevier
OBJECTIVES: Urinary bladder cancer is the fifth most common form of cancer in humans in
the United States. Urinary bladder cancer also occurs in pet dogs, and naturally-occurring …
the United States. Urinary bladder cancer also occurs in pet dogs, and naturally-occurring …
In vivo NIRF and MR dual-modality imaging using glycol chitosan nanoparticles
J Key, C Cooper, AY Kim, D Dhawan, DW Knapp… - Journal of controlled …, 2012 - Elsevier
One difficulty of diagnosing and treating cancer is that it is very challenging to detect cancers
in the early stages before metastasis occurs. A variety of imaging modalities needs to be …
in the early stages before metastasis occurs. A variety of imaging modalities needs to be …
Effects of short-term celecoxib treatment in patients with invasive transitional cell carcinoma of the urinary bladder
High-grade invasive transitional cell carcinoma (InvTCC) kills >14,000 people yearly in the
United States, and better therapy is needed. Cyclooxygenase-2 (Cox-2) is overexpressed in …
United States, and better therapy is needed. Cyclooxygenase-2 (Cox-2) is overexpressed in …
Cyclooxygenase inhibitors in urinary bladder cancer: in vitro and in vivo effects
SI Mohammed, D Dhawan, S Abraham… - Molecular cancer …, 2006 - AACR
More than 14,000 people die from invasive transitional cell carcinoma (TCC) of the urinary
bladder yearly in the United States. Cyclooxygenase (COX)-inhibiting drugs are emerging as …
bladder yearly in the United States. Cyclooxygenase (COX)-inhibiting drugs are emerging as …